• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鸟氨酸转氨甲酰酶缺乏症:新的突变概率增加位点。

Ornithine transcarbamylase deficiency: new sites with increased probability of mutation.

作者信息

Oppliger Leibundgut E O, Liechti-Gallati S, Colombo J P, Wermuth B

机构信息

Department of Clinical Chemistry, University of Berne, Inselspital, Switzerland.

出版信息

Hum Genet. 1995 Feb;95(2):191-6. doi: 10.1007/BF00209400.

DOI:10.1007/BF00209400
PMID:7860066
Abstract

Ornithine transcarbamylase (OTC) deficiency, the most common inborn error of the urea cycle, shows an X-linked inheritance with frequent new mutations. Investigations of patients with OTC deficiency have indicated an overproportionate share of mutations at CpG dinucleotides. These statistics may, however, be biased because of the easy detection of CpG mutations by screening for TaqI and MspI restriction sites. In the present study, we investigated 30 patients, with diagnosed OTC deficiency, for new sites with an increased probability of mutation by complete DNA sequence analysis of all ten exons of the OTC gene. In six patients, two codons in exons 2 and 5, respectively, contained novel recurrent mutations, all of them affecting CpG dinucleotides. They included C to T and G to A transitions in codon 40, changing an arginine to cysteine and histidine, respectively, and a C to T transition in codon 178 causing the substitution of threonine by methionine. The first two mutations were characterized by a mild clinical course with high risk of sudden death in late childhood or early adulthood, whereas the third mutation showed a more severe phenotypic expression. In addition to these novel mutations, we identified four patients with the known R277W mutation, making it the most common point mutation of the OTC gene.

摘要

鸟氨酸转氨甲酰酶(OTC)缺乏症是尿素循环中最常见的先天性代谢缺陷,呈X连锁遗传,且常有新的突变。对OTC缺乏症患者的研究表明,CpG二核苷酸处的突变比例过高。然而,这些统计数据可能存在偏差,因为通过筛查TaqI和MspI限制性酶切位点可轻松检测到CpG突变。在本研究中,我们通过对OTC基因的全部10个外显子进行完整的DNA序列分析,对30例确诊为OTC缺乏症的患者进行了研究,以寻找突变概率增加的新位点。在6例患者中,外显子2和5中的两个密码子分别出现了新的复发性突变,所有这些突变均影响CpG二核苷酸。它们包括密码子40中的C到T和G到A的转换,分别将精氨酸变为半胱氨酸和组氨酸,以及密码子178中的C到T的转换,导致苏氨酸被甲硫氨酸取代。前两个突变的临床病程较轻,但在儿童晚期或成年早期有较高的猝死风险,而第三个突变表现出更严重的表型表达。除了这些新突变外,我们还鉴定出了四名携带已知R277W突变的患者,使其成为OTC基因最常见的点突变。

相似文献

1
Ornithine transcarbamylase deficiency: new sites with increased probability of mutation.鸟氨酸转氨甲酰酶缺乏症:新的突变概率增加位点。
Hum Genet. 1995 Feb;95(2):191-6. doi: 10.1007/BF00209400.
2
Identification of new mutations in the ornithine transcarbamylase (OTC) gene in Korean families.韩国家族中鸟氨酸转氨甲酰酶(OTC)基因新突变的鉴定。
J Inherit Metab Dis. 1996;19(1):31-42. doi: 10.1007/BF01799346.
3
Missense mutations in codon 225 of ornithine transcarbamylase (OTC) result in decreased amounts of OTC protein: a hypothesis on the molecular mechanism of the OTC deficiency.鸟氨酸转氨甲酰酶(OTC)第225位密码子的错义突变导致OTC蛋白量减少:关于OTC缺乏分子机制的一种假说。
J Inherit Metab Dis. 1997 Nov;20(6):769-77. doi: 10.1023/a:1005363600268.
4
Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.在鸟氨酸转氨甲酰酶(OTC)缺乏症患者中鉴定出该基因的七个新错义突变、两个剪接位点突变、两个微缺失和一个多态性氨基酸替代。
Hum Mutat. 2002 Feb;19(2):185-6. doi: 10.1002/humu.9011.
5
Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype.鸟氨酸转氨甲酰酶缺乏症的基因型谱:与临床和生化表型的相关性。
Am J Med Genet. 2000 Aug 14;93(4):313-9. doi: 10.1002/1096-8628(20000814)93:4<313::aid-ajmg11>3.0.co;2-m.
6
Improved molecular diagnostics for ornithine transcarbamylase deficiency.鸟氨酸转氨甲酰酶缺乏症的分子诊断技术改进
Am J Hum Genet. 1991 Feb;48(2):212-22.
7
Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.对五名日本鸟氨酸转氨甲酰酶(OTC)缺乏症患者的OTC基因进行突变分析,发现了两个已知突变和三个新突变,其中包括一个内含子深处的突变。
Kobe J Med Sci. 2007;53(5):229-40.
8
Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site of the ornithine transcarbamylase gene.鸟氨酸转氨甲酰酶基因MspI位点由C突变为T导致的致命性高氨血症。
Hum Genet. 1991 Dec;88(2):153-6. doi: 10.1007/BF00206063.
9
Four novel gene mutations in five Japanese male patients with neonatal or late onset OTC deficiency: application of PCR-single-strand conformation polymorphisms for all exons and adjacent introns [corrected].5例日本男性新生儿或迟发性鸟氨酸转氨甲酰酶缺乏症患者中的4种新基因突变:聚合酶链反应-单链构象多态性在外显子及相邻内含子中的应用[已修正]
Hum Genet. 1993 Aug;92(1):49-56. doi: 10.1007/BF00216144.
10
Ornithine transcarbamylase deficiency resulting from a C-to-T substitution in exon 5 of the ornithine transcarbamylase gene.鸟氨酸转氨甲酰酶基因第5外显子中C到T的替换导致鸟氨酸转氨甲酰酶缺乏症。
Am J Hum Genet. 1989 Jul;45(1):123-7.

引用本文的文献

1
Pathogenic variants of ornithine transcarbamylase deficiency: Nation-wide study in Japan and literature review.鸟氨酸转氨甲酰酶缺乏症的致病变体:日本全国性研究及文献综述
Front Genet. 2022 Oct 11;13:952467. doi: 10.3389/fgene.2022.952467. eCollection 2022.
2
Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD).鸟氨酸转氨甲酰酶缺乏症(OTCD)中急性肝衰竭的发生率及病理生理学
PLoS One. 2016 Apr 12;11(4):e0153358. doi: 10.1371/journal.pone.0153358. eCollection 2016.
3
Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.

本文引用的文献

1
Four novel gene mutations in five Japanese male patients with neonatal or late onset OTC deficiency: application of PCR-single-strand conformation polymorphisms for all exons and adjacent introns [corrected].5例日本男性新生儿或迟发性鸟氨酸转氨甲酰酶缺乏症患者中的4种新基因突变:聚合酶链反应-单链构象多态性在外显子及相邻内含子中的应用[已修正]
Hum Genet. 1993 Aug;92(1):49-56. doi: 10.1007/BF00216144.
2
Four new mutations in the ornithine transcarbamylase gene.鸟氨酸转氨甲酰酶基因中的四个新突变。
Biochem Med Metab Biol. 1993 Oct;50(2):169-75. doi: 10.1006/bmmb.1993.1058.
3
Structure and expression of a complementary DNA for the nuclear coded precursor of human mitochondrial ornithine transcarbamylase.
鸟氨酸转氨甲酰酶缺乏症患者的临床结局及OTC基因突变谱
J Hum Genet. 2015 Sep;60(9):501-7. doi: 10.1038/jhg.2015.54.
4
Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment.成人OTC基因突变所致突发意外性致命性脑病——早期诊断及及时治疗的线索
Orphanet J Rare Dis. 2014 Jul 16;9:105. doi: 10.1186/s13023-014-0105-9.
5
Ornithine transcarbamylase deficiency combined with type 1 diabetes mellitus - a challenge in clinical and dietary management.鸟氨酸转氨甲酰酶缺乏症合并1型糖尿病——临床及饮食管理中的一项挑战。
J Diabetes Metab Disord. 2013 Jul 5;12(1):37. doi: 10.1186/2251-6581-12-37.
6
Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential.鸟氨酸转氨甲酰酶(OTC)缺乏症致病突变总数的估计。OTC结构在预测突变致病潜力方面的价值。
J Inherit Metab Dis. 2007 Apr;30(2):217-26. doi: 10.1007/s10545-007-0429-x. Epub 2007 Mar 1.
7
Mutation of ornithine transcarbamylase (H136R) in a girl with severe intermittent orotic aciduria but normal enzyme activity.一名患有严重间歇性乳清酸尿症但酶活性正常的女孩中鸟氨酸转氨甲酰酶(H136R)的突变。
J Inherit Metab Dis. 1997 Aug;20(4):517-24. doi: 10.1023/a:1005397329395.
8
Identification of four novel splice site mutations in the ornithine transcarbamylase gene.鸟氨酸转氨甲酰酶基因中四个新剪接位点突变的鉴定。
Hum Genet. 1996 Feb;97(2):209-13. doi: 10.1007/BF02265267.
9
A splicing mutation, a nonsense mutation (Y167X) and two missense mutations (I159T and A209V) in Spanish patients with ornithine transcarbamylase deficiency.
Hum Genet. 1995 Nov;96(5):549-51. doi: 10.1007/BF00197410.
人线粒体鸟氨酸转氨甲酰酶核编码前体的互补DNA的结构与表达
Science. 1984 Jun 8;224(4653):1068-74. doi: 10.1126/science.6372096.
4
Restriction sites containing CpG show a higher frequency of polymorphism in human DNA.含有CpG的限制性酶切位点在人类DNA中显示出更高的多态性频率。
Cell. 1984 Jan;36(1):131-8. doi: 10.1016/0092-8674(84)90081-3.
5
Isolation of genomic DNA.基因组DNA的分离
Methods Enzymol. 1987;152:180-3. doi: 10.1016/0076-6879(87)52018-3.
6
Characterization of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency.三名无关的鸟氨酸转氨甲酰酶缺乏症患者同一精氨酸密码子点突变的特征分析
J Clin Invest. 1988 Oct;82(4):1353-8. doi: 10.1172/JCI113738.
7
New mutation and prenatal diagnosis in ornithine transcarbamylase deficiency.鸟氨酸转氨甲酰酶缺乏症的新突变与产前诊断
Am J Hum Genet. 1986 Feb;38(2):149-58.
8
Structure of the human ornithine transcarbamylase gene.
J Biochem. 1988 Feb;103(2):302-8. doi: 10.1093/oxfordjournals.jbchem.a122265.
9
Ornithine transcarbamylase deficiency resulting from a C-to-T substitution in exon 5 of the ornithine transcarbamylase gene.鸟氨酸转氨甲酰酶基因第5外显子中C到T的替换导致鸟氨酸转氨甲酰酶缺乏症。
Am J Hum Genet. 1989 Jul;45(1):123-7.
10
Prenatal diagnosis and heterozygote detection by DNA analysis in ornithine transcarbamylase deficiency.
J Pediatr. 1989 Apr;114(4 Pt 1):582-8. doi: 10.1016/s0022-3476(89)80697-3.